HealthSTAT News
STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
One of the more impressive data sets at this year’s ESMO came from a Roche study of its drug divarasib, which treats lung cancer.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
One of the more impressive data sets at this year’s ESMO came from a Roche study of its drug divarasib, which treats lung cancer.
Join the argument
House rules →Comments load as you scroll.